Loading...

Placebo (n=147) Baricitinib 1-mg (n=147) Baricitinib 2-mg (n=146)

EASI75 at Week 16, n (%)

Placebo (n=147):

12 (8.2)

Baricitinib 1-mg (n=147):

19 (12.9)ǂ

Baricitinib 2-mg (n=146):

43 (29.5)***

vIGAª of 0 or 1 at Week 16, n (%)

Placebo (n=147):

8 (5.4)

Baricitinib 1-mg (n=147):

19 (12.9)*

Baricitinib 2-mg (n=146):

35 (24.0)***

4-point improvement in Itch NRS at Week 16, n (%)

Placebo (n=147):

7 (5.7)

Baricitinib 1-mg (n=147):

21 (15.9)*

Baricitinib 2-mg (n=146):

33 (25.2)***

Loading...